Companies Brace for Increased Hearings with Potential Democratic House

Law and lobbying firms in Washington, D.C., are advising companies to prepare for heightened scrutiny if Democrats win control of the U.S. House of Representatives. Historically, midterm elections often result in the loss of congressional control for the party that holds the White House. This potential shift could lead to more hearings and investigations into business practices, particularly focusing on tech and pharmaceutical companies, according to some reports. These hearings might examine issues such as data privacy, antitrust concerns, and drug pricing, among others.

For companies, this means increased legal and regulatory challenges as they may face more intense oversight and public scrutiny. Being prepared for such a scenario could involve bolstering compliance departments and engaging in proactive lobbying efforts to mitigate potential regulatory impacts.